Mesirow Financial Investment Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,534	Closed	-$220K	–	619
2025 Q1	$220K	Hold	16,534	–	–	﹤0.01%	521
2024 Q4	$317K	Buy	16,534 +184	+1%	+$3.53K	0.01%	446
2024 Q3	$372K	Buy	+16,350	New	+$372K	0.01%	411